Schedule 13D ownership disclosure

APREA THERAPEUTICS INC

Security class unavailable · CUSIP: 03836J102

Event date: 2022-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-186226
Form type
SC 13D/A
Filer
Aprea Therapeutics, Inc.
CIK
CIK 1781983
Filed
Jun 30, 2022
Reporting period
Jun 30, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub